Fulvic acid compositions and their use
OwnerStephen William Leiversinventor
Life of this patent
Estimating the term…
Abstract
Carbohydrate-derived fulvic acid (CHD-FA), a salt, ester or derivative thereof for use in the prevention, treatment or inhibition of infection by oral pathogens in a mammal, compositions, particularly compositions suitable for oral administration, comprising the same.
Claims18
An oral pharmaceutical composition for preventing, treating or inhibiting an infection by an oral pathogen, comprising:
- (a) carbohydrate-derived fulvic acid (CHD-FA), a salt, ester or derivative thereof as active ingredient;
- and
- (b) a pharmaceutically acceptable carrier for oral administration of the active ingredient.
-3. (canceled)
The pharmaceutical composition according to claim 3, in which the active ingredient is present in an amount from about 8% to 60% v/v of the composition.
(canceled)
-12. (canceled)
A method of preventing, treating or inhibiting infection by an oral pathogen in a mammalian subject in need thereof, comprising administering to the subject an effective amount of a pharmaceutical composition that comprises:
- (a) CHD-FA, or a salt, ester or derivative thereof;
- and
- (b) a pharmaceutically acceptable carrier for oral administration.
Dependencies are inferred from the claim text.